ARTICLE | Company News
Intellikine, Numerate deal
August 16, 2010 7:00 AM UTC
Intellikine and Numerate mutually ended a 2009 deal to use Numerate's computational drug design technology to discover a "small number" of compounds against phosphoinositide 3-kinase (PI3K) alpha. In...